Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

(1997): Thaler D, Monona, WI (from Internet) (observation)
(1996): Litt JZ, Beachwood, OH (from Internet) (observation)
(1990): Medina I+, NEnglJMed323, 776 (1–5%)
(1987): Colebunders R+, AnnInternMed107, 599 (4% in AIDS)
(1986): Sher MR, J Allergy Clin Immunol 77, 133
(1984): Kramer BS+, Cancer 53, 329
Pruritus ani et vulvae
(1981): Modern Medicine 49, 111
Psoriasis
Purple gloves and socks syndrome
(1999): van Rooijen MM+, Hautarzt (German) 50, 280
Purpura
(1993): Kaufman DW+, Blood 82, 2714
(1989): Saxena SK, J Assoc Physicians India 37, 479
Pustules
(1994): Spencer JM+, Br J Dermatol 130, 514
(1990): Guy C+, Nouv Dermatol (French) 9, 540
(1989): Grattan CEH, Dermatologica 179, 57 (passim)
(1986): Macdonald KJS+, BMJ 293, 1279
Rash (sic) (>10%)
(2001): Meyers B+, Liver Transpl 7(8), 750
(2000): Talan DA+, JAMA 283, 1583 (14%)
(1995): Williams JW+, JAMA 273, 1015
(1993): Malnick SD+, Ann Pharmacother 27, 1139
(1984): Gordin FM+, AnnInternMed100, 495
Side effects (sic)
(1994): Roudier C+, Arch Dermatol 130, 1383 (48% in AIDS
patients)
Stevens–Johnson syndrome (1–10%)
(2006): Gimnig JE+, Am J Trop Med Hyg 74(5), 738
(2006): Panagotacos P, San Francisco, CA (personal
communication)
(2001): Brett AS+, South Med J 94, 342
(1998): Arola O+, Lancet 351, 1102 (trimethoprim)
(1998): Siegfried EC+, JAmAcadDermatol39, 797 (passim)
(1997): Douglas R+, Clin Infect Dis 25, 1480 (2 cases)
(1997): Rieder MJ+, Pediatr Infect Dis J 16, 1028 (10% in
children with HIV)
(1996): Caumes E, Rev Mal Respir (French) 13, 101
(1996): Eastham JH+, Ann Pharmacother 30, 606
(1996): McCarty J, Fort Worth, TX (from Internet) (observation)
(1995): Jick H+, Pharmacotherapy 15(4), 428
(1995): Kuper K+, Ophthalmologe (German) 92, 823
(1995): Lewis RJ, Br J Rheumatol 34, 84
(1995): Sharma VK+, Pediatr Dermatol 12, 178
(1995): Wolkenstein P+, Arch Dermatol 131, 544
(1994): Shelley WB+, Cutis 53, 159 (observation)
(1993): Gompels M+, IntJSTDAIDS4(5), 293
(1993): Litt JZ, Beachwood, OH (personal case) (observation)
(1990): Chan HL+, Arch Dermatol 126, 43
(1988): Platt R+, JInfectDis158, 474
(1987): Schopf E, Infection 15 Suppl 5, S254 (1%)
(1985): Heer M+, Gastroenterology 88, 1954
(1982): Brettle RP+, JInfect4, 149
Toxic epidermal necrolysis (1–10%)
(2006): Gimnig JE+, Am J Trop Med Hyg 74(5), 738
(2002): Correia O+, Arch Dermatol 138, 29 (3 cases)
(2002): John T+, Ophthalmology 109(2), 351
(2002): Nassif A+, J Invest Dermatol 118(4), 728
(2001): Paquet P+, Burns 27(6), 652
(2001): See S+, Ann Pharmacother 35(6), 694
(2001): Spies M+, Pediatrics 108, 1162
(2000): Moussala M+, JFrOphtalmol(French) 23, 229
(2000): Yang CH+, Int J Dermatol 39, 621 (with methotrexate)
(1999): Egan CA+, JAmAcadDermatol40, 458 (6 cases)
(1998): Arora VK+, Indian J Chest Dis Allied Sci 40, 125
(1998): Rademaker M+, New Zealand Adverse Drug Reactions
Committee, April, 1998 (from Internet)
(1998): Siegfried EC+, JAmAcadDermatol39, 797 (passim)
(1996): Caumes E, Rev Mal Respir (French) 13, 101
CO-TRIMOXAZOLE 143
(1996): Rehbein H, Jacksonville, FL (from Internet) (observation)
(1996): Wagner FF+, NEnglJMed334, 922
(1995): Jick H+, Pharmacotherapy 15, 428
(1995): Sharma VK+, Pediatr Dermatol 12, 178
(1995): Wolkenstein P+, Arch Dermatol 131, 544 (7 cases)
(1993): Correia O+, Dermatology 186, 32
(1990): Chan HL+, Arch Dermatol 126, 43
(1990): Kobza Black A+, Br J Dermatol 123, 277
(1990): Roujeau JC+, Arch Dermatol 126, 37
(1990): Ward DJ+, Burns 16, 97
(1989): Carmichael AJ+, Lancet 2, 808
(1989): Whittington RM, Lancet 2, 574
(1988): De Raeve L+, Br J Dermatol 119, 521 (passim)
(1987): Guillaume JC+, Arch Dermatol 123, 1166
(1987): Schöpf E, Infection 15 (Suppl 5P), S254
(1986): Miller KD+, Am J Trop Med Hyg 33, 451
(1986): Revuz J, JDermatolParis153 (abstract)
(1986): Roman O+, Rev Pediatr Obstet Ginecol Pediatr
(Romanian) 35, 261
(1984): Fong PH+, Singapore Med J 25, 184
(1984): Westly ED+, Arch Dermatol 120, 721
(1983): Petersen P+, Ugeskr Laeger (Danish) 145, 3345
(1982): Ortiz JE+, Ann Plast Surg 9, 249
Urticaria
(2006): Padilla Serrato MT+, Rev Alerg Mex 53(5), 179
(2005): Feiza BA+, Tunis Med 83(11), 714
(1994): Blumenthal HL, Beachwood, OH (personal case)
(observation)
(1993): Litt JZ, Beachwood, OH (personal case) (observation)
(1991): Greenberger PA, JAMA 265, 458
(1987): Schöpf E, Infection 15 (Suppl 5P), S254
(1985): Goolamali SK, Postgrad Med J 61, 925
(1985): Maayan S+, Arch Intern Med 145, 1607
(1984): Kramer BS+, Cancer 53, 329
(1981): Abi-Mansur P+, Am J Gastroenterol 76, 356
Vasculitis
(2005): Feiza BA+, Tunis Med 83(11), 714
(1998): Tonev S+, J Eur Acad Dermatol Venereol 11, 165
(1995): Lewis RJ, Br J Rheumatol 34, 84
(1989): Verne-Pignatelli J+, Postgrad Med J 65, 51
(1987): Schöpf E, Infection 15 (Suppl 5P), S254
Mucosal
Aphthous stomatitis
(1981): J Antimicrob Chemother 7, 179
Genital ulceration
(2001): Cherian G, Int J Clin Pract 55(2), 151
Gingival hyperplasia/hypertrophy
(1997): Caron F+, Therapie (French) 52, 73
Glossitis
Mucocutaneous syndrome
(1982): Brettle RP+, JInfect4, 149
Oral mucosal eruption
(1991): Tilden ME+, Arch Ophthalmol 109, 67
(1988): Fihn SD+, AnnInternMed108, 350 (1–5%)
Oral ulceration
(1987): Hughes WT+, NEnglJMed316, 1627
(1981): Orenstein WA+, Am J Med Sci 282, 27
Stomatitis (